翰思艾泰-B（03378.HK）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

私营企业79.49%
公众及其他12.05%
上市公司4.72%
机构投资者2.32%
个人与内部人士1.43%

主要股东

主要股东最新
股东
Cai Zhang Biotechnology (Hangzhou) Co., Ltd	40.60%	5,530.00 万	0.00%	+0	2025/12/31
Hanx Biopharmaceuticals (HK) Limited	13.06%	1,779.36 万	0.00%	+0	2025/12/31
Hangzhou Hongye Ruiji Investment Partnership (Limited Partnership)	9.44%	1,286.05 万	0.00%	+0	2026/01/08
Beijing Lapam Biopharmaceutical Venture Capital Center (Limited Partnership)	9.44%	1,286.05 万	0.00%	+0	2026/01/08
Betta Pharmaceuticals Co., Ltd.	4.72%	643.02 万	0.00%	+0	2025/12/23
Wuhan Donggaorensi Equity Investment Partnership (Limited Partnership)	2.51%	341.61 万	0.00%	+0	2025/12/23
Wuhan Hanx Tai Management Consulting Partnership (L.P.)	2.24%	304.51 万	0.00%	+0	2025/12/31
Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)	1.88%	256.21 万	0.00%	+0	2025/12/23
Yangtze Investment (HK) Limited	1.32%	180.40 万	0.00%	+0	2025/12/23
Qixiang LiCEO, CSO, GM & Executive Director	1.00%	136.64 万	0.00%	+0	2025/12/31
Tibet Lapam Small and Medium Enterprise Development Fund Equity Investment Partnership (Limited Part	0.88%	119.56 万	0.00%	+0	2026/01/08
Lapam Capital	0.44%	59.60 万	0.00%	+0	2026/01/08
Min LiuCOO, Vice GM & Executive Director	0.40%	54.66 万	0.00%	+0	2025/12/31
Liao Tong	0.02%	2.14 万	0.00%	+0	2025/12/23
Jieyu XiaoCFO, Secretary of the Board & Executive Director	<0.01%	1.11 万	0.00%	+0	2025/12/31
Zou Zhiyong	<0.01%	1,710.00	0.00%	+0	2025/12/23